Seasonal Flavonoid Profile and Kaempferitrin Content in the Leaf Extracts of Bauhinia forficata Subspecies forficata from Two Locations in Southeastern Brazil

The leaves of Bauhinia forficata L. (Fabaceae) are used in Brazilian folk medicine mainly as antidiabetic agent. They are rich in polyphenols, and kaempferitrin and other flavonoids are currently considered as basic chemical criteria for the quality and the effectiveness of extracts and phytopharmaceuticals derived from them. Aiming to expand the scope of current data of the chemical profile of B. forficata subsp. forficata, the present study employed HPLC-DAD and HPLC-DAD-ESI/MS to compare the flavonoid profile and kaempferitrin content in the leaves of specimens collected seasonally during one year, in two different locations in Southeastern Brazil: Rio de Janeiro (RJ) and São Paulo (SP) states. The data showed a variation in the flavonoid profile and in the kaempferitrin content depending on the place of collection and the season of the year. The target compound, kaempferitrin, was found to be only a minor constituent in RJ (0.21 1.02 μg/mg), and was mostly absent or occurred as trace in SP location (0.00 0.12 μg/mg). Some degree of similarity was observed in the flavonoid profiles according to the region of collection. In agreement with some published reports, the low and quite variable kaempferitrin content as well the wide variability of the flavonoid profiles brings into question the dubious matter of using these compounds as chemical markers for this medicinal species.


Introduction
Bauhinia forficata Link (Fabaceae) is a medium-sized tree found in Southeastern and Southern Brazil, popularly known as pata-de-vaca (cow's hoof) due to the bilobed shape of its leaves [1].These leaves are used in the folk medicine in Brazil and other South American countries as helping in diabetes treatment insofar it presents a noteworthy anti-hyperglycemic action [2] [3] [4] [5] [6].Currently, the Brazilian Health Ministry rolls this species among the priorities ones for scientific validation, toward developing a sugar-lowering phytopharmaceutical [7].
A number of studies have demonstrated the antidiabetic property of aqueous, alcoholic and aqueous-alcoholic extracts from the leaves of Bauhinia species [5] [8].In the line, the researchers have striven to correlate the hypoglycemic effect to the chemical content of Bauhinia species, in particular the flavonoid-enriched fraction [9] and the individual constituent kaempferitrin (kaempferol-3,7-O-αdirhamnoside) (Figure 1) [10] [11].
Since it was firstly reported as a marked component in the methanolic extract of B. forficata leaves [12], the flavonoid kaempferitrin has drawn the attention as a possible responsible for the antihyperglycemic activity.This hypothesis was later proven correct when a significant hypoglycemic effect was observed in normal rats as well as in alloxan-induced diabetic animals, by administering different doses of kaempferitrin isolated from the hydroethanolic leaf extract of B. forficata, followed by solvent partitioning and flash column chromatography [13].Kaempferitrin was then employed to assess the quality of B. forficata Link by quantifying such a compound in diverse hydroalcoholic extracts, an approach that included comparing leaves collected in different locales [14] as well as commercial dried samples [15].However, kaempferitrin was not detected in every sample of B. forficata leaves thereafter approached.For instance, a NMR-based investigation on the constituents of the leaf hydroalcoholic extract led to the characterization of other 7-O-rhamnopyranosyl derivatives of kaempferol and quercetin, including di-and tri-glycosides [16].Furthermore, the LC/ESI-MS analysis of the leaf extract of B. forficata did not reveal the presence of kaempferitrin but instead characterized four other quercetin and kaempferol glycosides as constituents [17].Ferreres et al. [18] by analyzing commercial and authentic samples of B. forficata towards α-glucosidase inhibitory activity suggested that the higher amounts of quercetin derivatives found in some samples could be responsible for their higher activities when compared to those samples rich in kaempferol derivatives.
On the other hand, Farag et al. [19] studying Egyptian Bauhinia spp.have observed by chemometric approaches no correlation between total flavonoid content and α-glucosidase inhibition for B. forficata, which was speculated be related to the major content of flavonoid glycosides instead of free flavonoids.Furthermore, other kaempferol and quercetin glycosides were reported to be involved on the glucose-6-phosphatase inhibition effect of B. megalandra leaves [20] while a megastigmane glycoside from B. variegata was shown to increase insulin secretion [21].Moreover, other compound present in the B. forficata leaf extract, as trigonelin, quercetin, rutin and other flavonol glycosides [22] [23], are endowed with antidiabetic activity [24].
There is nowadays a growing concern onto considering a polyphenols/flavonoid more unfolded profile to authenticate and control the quality of B. forficata samples.Efforts have been made to develop and apply analytical methods to establish the qualitative and/or quantitative polyphenolic compounds [17] [18] [25].In such a context, dosing of kaempferitrin content remains relevant, regarding the background of this compound as hypoglycemic agent [14] [15] [26] [27].Overall, the results have shown a wide variation on kaempferitrin content and polyphenolic profiles among commercial samples and those from different locations and seasons, including the two B. forficata subspecies: forficata and pruinosa [18] [25] [26] [27] [28] [29].
Previous studies involving the seasonal and/or location influence in the kaempferitrin content and the flavonoid profile and content of B. forficata leaves have been done with a single exemplar from each location or specific season [14] [15] [18] [26] [29].In order to contributing to expand the data of the chemical profile of B. forficata, the present study aims at comparing the flavonoid profile and kaempferitrin content in leaves of the species seasonally collected during about one year in two different locations in Southeastern Brazil.Kaempferitrin quantification was achieved by HPLC-DAD.UPLC-ESI-MS was employed as complementary technique to putatively establish the kind of glycosides present in the extracts.

Preparation of the Extracts
The extracts were prepared using a modified procedure previously developed to assess the kaempferitrin content from the leaves of Uncaria guianensis [23].After drying at room temperature, grinding in a stainless-steel blender and then sieving to particle size ≤ 0.177 mm, 250 mg of B. forficata leaves were extracted with 9.5 mL of MeOH with ultrasound assistance for 18 min.The mixture was centrifuged, the supernatant was separated, and the process repeated five times.
The supernatants were pooled, and the solvent was evaporated under low pressure.Extract yields were determinate on dried weight.

HPLC-DAD Analyses
The HPLC analyses were performed using Shimadzu (VP) equipment with two membranes (Sartorius) and then injected in duplicate.The kaempferitrin quantification was done through an external calibration curve using aprevious isolated sample (Section 2.1).Five concentration levels of the reference compound were prepared in methanol (1.30, 2.60, 9.75, 32.30 and 65.00 µg/mL).Each level was injected in triplicate to yield the calibration curve (R 2 = 0.9999) derived from the equation y = 87272x − 33684, where y is the peak area and x the con-DOI: 10.4236/ajps.2019.101016centration (μg/mL).Kaempferitrin in the extracts was quantified against this calibration curve.The results were later converted to μg/mg extract.The linearity and validity of the calibration curve were supported by ANOVA test.The quantitation limit (QL) was considered as the lowest point of the curve, i.e. 1.30 µg/mL (0.09 µg/mg).The confirmation of the kaempferitrin peak in the extracts was performed by fortification of three selected samples (SP-T1-JUL2009, SP-T2-DEC2009 and RJ-NOV2009) with 1 -3 µL of the reference compound in methanolat c = 130 µg/mL.This value was calculated in order to enhance the original area by about three times.Two injections of each sample (original and fortified) were carried out and the respective area's integrations were used to corroborate the peak identity.

Results and Discussion
In our study, evaluation of the flavonoid profile and kaempferitrin content in B. the samples from SP than those from RJ (Table 1).The HPLC-DAD chromatograms of the extracts from the several collections showed a steady qualitative profile in the RJ samples and a noticeable variation in the flavonoid profile in the SP samples.No correlation between the chemical profiles and time of collection or different trees was observed, although some chromatograms similarity could be inferred regarding the site of collection (Figure 2).In these cases, the contents of kaempferitrin could be inferred from the calibration curve; however, such an extrapolation was eventually considered worthless (Table 1).
Overall, our data corroborates some previously reports on the chemical variability of the flavonoid profile in B. forficata leaves [14] [19] [25].The extracts approached in this study showed the predominance of glycosylated flavonols, which were primarily characterized by their R t (based on the R t of kaempferitrin used as reference) and by their UV spectra as derivatives of kaempferol (λ MAX ~265 nm), quercetin or isorhamnetin or myricetin (λ MAX ~255 nm) [31] (Figure 2).All these compounds have been previously described in the leaves of this species [17] [18] [23] [25].Yet, erratic concentrations [26] [32] or even the absence [17] of kaempferitrin in B. forficata leaves from diverse geographical origins has already been reported during the development and validation of spectrometric methods to quantify the flavonoid pool in this plant matrix.
Also in accordance with the literature, most of flavonoid constituents-herein DOI: 10.4236/ajps.2019.101016 emphasizing the major ones-were kaempferol derivatives.The degree of the aglycones glycosylation was suggested by the quasi molecular ion [M-H] − obtained from the UPLC-ESI-MS operating in the negative mode (Table 2).In most of the cases, the UV-suggested aglycones were corroborated by the occurrence of their respective fragment in the mass spectrum.These results align well with those obtained from the detailed analysis performed by Ferreres et al. when approaching the leaves of B. forficata from Southern Brazilian, using a variation of the same technique employed here [18].
Some researchers have also caught the attention to the unavailability of re-  1 For peak numbering see Figure 2. Peaks 1 and 2 afforded identical UV spectra, but were not separated in the HPLC-MS experiment. 2 Trace level in most of the SP samples (see text).K = kaempferol, Q = quercetin, I = isorhamnetin. 3LC-ESI-MS in negative mode applied to samples RJ-MAR2011 and SP-T3-AUG2009 (see experimental and Table 1).Excepting peak 7 (20%), all others showed [M-H]-ion as the base peak. 4Based on the UV typical profiles [31] and comparing MS data with those reported in [18] and [27]; K = kaempferol; Q = quercetin, I = isorhamnetin.Most spectra showed fragments corresponding to K (m/z 283) or Q (m/z 301) aglycones.
compounds by the plant [34].Also stressing conditions from oxidative or hydric unbalance, for instance, can modify the plants biosynthetic pathway and induce them to produce chemical defenses in response to changes in the habitat [35] [36].All these nuances have to be duly considered when aiming standardization of medicinal extracts [37].
Finally yet importantly, most of the early reports in the literature on chemical and biological properties of B. forficata Link have approached such a species as a particular botanical entity, disregarding possible morphological distinctions that encompass, for instance, subspecies or possible varieties.In this context, taxonomic studies have been gradually evolve toward consolidating two subspecies growing in Brazil: Bauhinia forficata Link subsp.forficata and Bauhinia forficata subsp.pruinosa (Vogel) Fortunato & Wunderlin [38] [39] [40].Both of these thrive in the Brazilian Atlantic forest, with the latter being more densely reported in southern areas and frontier countries.Conversely, the former one spreads along the upside subequatorial forest, eventually appearing in Northeastern tropical areas [40].
Recent compilation in the literature reveals that researchers have been alert to considering such a taxonomic detail [17] [18] [22] [27].However, with rare exceptions [22], such data usually do not accompany the set of information provided during the sale of plant raw material and the subspecies identification remains lacking in some reports elsewhere [23] [41].On comparing the flavonoid profile of Bauhinia forficata subsp.pruinosa and a commercial sample of Bauhinia forficata (non-determined subspecies), Ferreres et al. demonstrated their quite different phenolic profiles, particularly concerning to the content and type of glycosylated aglycones present in each one.This feature was also suggested by the authors as implying of distinct levels of biological responses [18].The present study is the first to approach the polyphenol profile of B. forficata subsp.forficata botanically certified.

Concluding Remarks
The data presented in this study show the complex question of considering the phenolic content of Bauhinia forficata leaves-be it the flavonoid profile or another phenolic group profile, or even an individual compound-as a tool to the quality control of the vegetal raw material, herbal and phytopharmaceutical derived from this species.Additionally, the spontaneous growth of two B. forficata subspecies regarded as anti-hyperglycemic also demonstrates the need for a precise botanical classification when approaching medicinal properties of this species.Further studies on the correlation between the chemical composition and therapeutic property of this important antidiabetic species are necessary.
forficata subsp.forficata leaves was carried out with plants collected seasonally during approximately one year in two different places of the Brazilian Southeast region, with differing altitude and climate (seaside town of Rio de Janeiro, RJ and Valinhos in the interior of São Paulo, SP].The extract yields, although not-statistically considered, pointed to lower amounts and greater variation in DOI: 10.4236/ajps.2019.101016

Table 1 .
Methanol extract yields and kaempferitrin content in leaves of Bauhinia forficata subsp.forficata seasonally collected in two different localites in Brazil.

Table 2 .
[33]ntidiabetic activity of other kaempferol glycosides that are usually present in the B. forficata extracts[16][26][33]. Thereby, the emerging question concerns to achieve a steady and reproducible chromatographic profile, based on either an individual compound or a group of phenolics, aiming at establishing a fingerprint to refer the quality of the raw material, herbal drug or phytopharmaceutical derived from this important medicinal species.As being a current issue in this standardizing context, the virtual absence of kaempferitrin in the extracts has to be carefully considered.In spite of the some advances in the quality control of the raw material, developing medicinal products from this species requires extending studies in order to achieve the optimum correlation between efficacy and chemical profile for B. forficata extracts.Additionally, it is well known that environmental factors such as seasonality, circadian rhythm, radiation, temperature, altitude and humidity can modify the secondary metabolism thus interfering quantitatively and qualitatively in the production of UV and MS data of some flavonoids from leaf methanol extracts of Bauhinia forficata subsp.forficata from two different localities in Brazil.